Stephen Moloney

Stephen Moloney, MD has extensive experience in medical affairs, holding various leadership positions in pharmaceutical companies such as Alkeus Pharmaceuticals, Crinetics Pharmaceuticals, Strongbridge Biopharma plc, PTC Therapeutics, Aegerion Pharmaceuticals, Shire Pharmaceuticals, Aspreva Pharmaceuticals, GlaxoSmithKline, and AstraZeneca. With a Doctor of Medicine degree from the University of Bristol, Stephen has successfully led global medical teams, guided prelaunch and launch plans for rare disease products, and developed strategic medical communications and education programs.